Showing results (601-610 of 647) with videos related to

Sort By:
Pageof 65
Neuron|June 8, 2015
Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric DisordersJanine Arloth, Ryan Bogdan, Peter Weber, et al.
Nature Communications|April 24, 2021
The impact of non-additive genetic associations on age-related complex diseasesMarta Guindo-Martínez, Ramon Amela, Silvia Bonàs-Guarch, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smokingBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
International Journal of Cancer|August 2, 2014
Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell linesNadine C Olthof, Christian U Huebbers, Jutta Kolligs, et al.
Tumour Virus Research|April 23, 2022
Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adultsJames Riddell, Andrew F Brouwer, Heather M Walline, et al.
Obesity (Silver Spring, Md.)|April 19, 2013
Racial/ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in childrenMichael Rosenbaum, Ilene Fennoy, Siham Accacha, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2018
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinomaJacqueline E Mann, Joshua D Smith, Andrew C Birkeland, et al.
Head & Neck|February 26, 2017
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell linesHeather M Walline, Christine M Goudsmit, Jonathan B McHugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
Investigational New Drugs|May 27, 2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancerPaul L Swiecicki, Emily Bellile, Assuntina G Sacco, et al.
Pageof 65